IMAX’s (IMAX) “Outperform” Rating Reiterated at Wedbush

Wedbush reiterated their outperform rating on shares of IMAX (NYSE:IMAX – Free Report) in a research note released on Friday morning, MarketBeat reports. The brokerage currently has a $22.00 target price on the stock. Wedbush also issued estimates for IMAX’s FY2023 earnings at $0.53 EPS. Other analysts have also recently issued reports about the stock. […]

Leave a Reply

Your email address will not be published.

Previous post Seres Therapeutics, Inc. (NASDAQ:MCRB) Given Average Recommendation of “Moderate Buy” by Brokerages
Next post Johnson Controls International (NYSE:JCI) Cut to Neutral at Mizuho